logo
Restaino says paper dabbling in 'conspiracy' over arena study release

Restaino says paper dabbling in 'conspiracy' over arena study release

Yahoo12-06-2025
Hours after the Niagara Gazette filed a formal request for a copy of the draft feasibility study for his proposed Centennial Park project, Mayor Robert Restaino accused the newspaper of conjuring up a 'conspiracy' about his administration's lack of transparency where the release of the document's contents is concerned.
The Gazette on June 5 filed a Freedom of Information Law request with the city clerk's office, seeking a copy of the Centennial Park feasibility study prepared by Florida-based consultant, Sports Facilities Advisory, LLC.
In an interview last month with local media members, Restaino confirmed that the consulting firm provided his office with what he described at the time as an incomplete version of the study.
In its FOIL request, the newspaper asserts that, even in a draft form, the study — commissioned to assess various aspects of the project, including potential locations — warrants release under state law.
Restaino has said that he intends to release the study's findings before the end of June, once he has shared them with 'stakeholders,' specifically representatives from the state-run economic development agency, Empire State Development Corp. and National Grid.
Both entities provided the city with a total of $140,000 used to hire Sports Facilities Advisory to analyze the proposed arena and events campus Restaino wants to build across from Seneca Niagara Resort & Casino on 10 acres of land currently owned by the private firm Niagara Falls Redevelopment.
On Friday, in a weekly update posted to the mayor's office YouTube channel, Restaino denied any 'failure to disclose' on his administration's part, while describing the Gazette's coverage as being part of a 'narrative that really has no basis in fact.'
'It's more about spinning things, how can they convince people about a conspiracy,' Restaino said.
The mayor again indicated that he intends to make the results of the study public before the end of the month.
'There's never been a suggestion that it's not going to be disclosed to the public, never insinuated that it wasn't going to be disclosed to the public,' Restaino said on Friday.
'You know how crack reporting is,' the mayor added. 'They like to find some conspiracy in everything. Unfortunately, I don't think they've listened carefully to what has been said and that is, for a period of time, it was just getting the additional information that was necessary so that the feasibility study could be complete. Also, sharing the feasibility study with the entities that financed it. Ultimately, the feasibility study can and will be disclosed to the entire public, everybody. Everybody will have access to it. Everybody will know what is contained in it.'
The city issued a request for proposals for the 'Centennial Park Market Analysis and Feasibility Study' on Oct. 2, 2023. The RFP sought qualified firms to perform the market analysis and feasibility study based on the 'conceptual design' for the project. The objective of the study was to assist the city in determining 'if and where to build a project of this nature.' The RFP required the preferred consultant to complete five tasks, including:
• Needs assessment. This task involved using the city's concept plan to identify potential Centennial Park programming. Suggestions listed in the RFP included athletic programs, winter activities, learning spaces and event spaces.
• Site analysis. Under this task, the preferred consultant was expected to examine the utility and other infrastructure needs for the project as well as look at the proposed NFR site and 'other potential alternative sites' for the project.
• Market analysis. This task involved a look at the facility's potential use by outside groups and an examination of comparable facilities and an assessment of competition within the market. It also called for an estimate on the approximate number and type of events such a facility could reasonably expect to host per year and probable attendance figures.
• Financial analysis. This task sought information about preliminary capital budget development, facility funding options, preliminary operating budget and potential revenue streams to support the facility.
• Presentation of findings. Under the RFP, the preferred consultant was expected to prepare to 'present and defend' their findings to the mayor, other city officials and stakeholders prior to the conclusion of the study. The RFP notes that the process 'may' include in-person and virtual meetings with both elected officials and the general public.
The city clerk's office acknowledged receipt of the Gazette's FOIL request on June 5, noting that, under state law, the city has 20 business days to either deny or grant the study's release. In the response, the clerk's office indicated that the city would advise the newspaper of a 'new estimated response date' should 'circumstances arise' that would prevent the city from responding within 20 business days.
'Examples of circumstances that may lead to extended response times include staff shortages, requests for a large volume of records and requests that require significant document redaction and/or seek documents that are not maintained electronically,' the response from the clerk's office notes.
Under state Freedom of Information Law, the city can grant the newspaper's request, deny it or deny it in part. State law outlines specific circumstances under which public agencies can deny requests for copies of documents considered to be matters of public interest. The law also allows agencies to redact information contained in documents under limited circumstances.
Council Chairman Jim Perry last week acknowledged that he has talked about the feasibility study with Restaino but said he has not actually seen the unfinished product. He indicated that he considered the study the mayor's to release publicly, adding that, from what he's been told, it is largely 'positive' where the Centennial Park project is concerned.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Global High-Throughput Screening Market to Surpass USD 50.2 Billion by 2029
Global High-Throughput Screening Market to Surpass USD 50.2 Billion by 2029

Yahoo

timea minute ago

  • Yahoo

Global High-Throughput Screening Market to Surpass USD 50.2 Billion by 2029

Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- North America Leads Today, Asia Pacific to Record Fastest GrowthThe global high throughput screening market, valued at US$25.7 billion in 2023, stood at US$28.8 billion in 2024 and is projected to advance at a resilient CAGR of 11.8% from 2024 to 2029, culminating in a forecasted valuation of US$50.2 billion by the end of the period. This growth is propelled by surging R&D investments in drug discovery, strategic government funding, and the increasing adoption of automation in life sciences research. Download PDF Brochure: What Is Driving the Market Now?HTS adoption is accelerating due to innovations in automation, miniaturization, and high-content screening, which significantly reduce discovery timelines and enhance precision in identifying therapeutic candidates. Grants such as the USD 7.8 million awarded to the University of Pittsburgh for advanced drug discovery systems underscore growing institutional and government commitment to high-impact research. Why Does This Matter for Global Pharma and Biotech Leaders?The market represents a critical enabler for competitive advantage in lead discovery, target validation, compound profiling, and hit identification—processes essential for pipeline acceleration. While high instrument costs remain a barrier, particularly for automated liquid handling and high-resolution imaging systems, emerging markets such as China and India offer lucrative opportunities with strong government support and an expanding pharmaceutical manufacturing base. Who Are the Key Stakeholders?The HTS ecosystem spans pharmaceutical giants, biotechnology innovators, academic institutions, and technology providers, all collaborating to enhance assay development and manage the rising complexity of biological data. The consumables segment—driven by recurring purchases of reagents and kits—dominates the market, ensuring steady demand as HTS workflows expand globally. Request Sample Pages: Where Is Growth Coming From? North America currently leads, fueled by advanced HTS infrastructure, robust funding for life science research, and a thriving biotech sector. Asia Pacific is projected to be the fastest-growing region, supported by a diverse patient base, strong pharmaceutical capabilities, and favorable regulatory environments. How Are Market Leaders Responding? Thermo Fisher Scientific Inc. maintains global leadership through an extensive portfolio of automated systems, screening instruments, and consumables, underpinned by 3% annual R&D investment and strategic alliances. Agilent Technologies, Inc. offers highly customizable workflows via BioTek detection instruments and Gen6 software, strengthened by acquisitions such as e-MSion (US) to enhance mass spectrometry capabilities. Merck KGaA delivers a diverse portfolio of reagents, instruments, software, and services, leveraging global reach and deep customer relationships across pharma, academia, and government sectors. Market OutlookAs automation, AI-driven data analysis, and advanced assay development converge, HTS will remain at the forefront of pharmaceutical innovation. Decision-makers who strategically invest in HTS capabilities today will be best positioned to accelerate therapeutic pipelines, capture market share, and deliver faster, more targeted treatments to market. For more information, Inquire Now Discover Connected Healthcare Market Opportunities:Drug Screening MarketCarrier Screening MarketCell based Assays MarketLabel Free Detection MarketLife Science Instrumentation Market Get access to the latest updates on High-Throughput Screening Companies and High-Throughput Screening Market Size CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445, USA: +1-888-600-6441 Email: sales@ Visit Our Website: while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Year's Biggest US IPO Is Also Biggest Flop as Earnings Fizzle
Year's Biggest US IPO Is Also Biggest Flop as Earnings Fizzle

Yahoo

time20 minutes ago

  • Yahoo

Year's Biggest US IPO Is Also Biggest Flop as Earnings Fizzle

(Bloomberg) -- Venture Global Inc.'s crown as worst US public markets debutant this year is undented after the liquefied natural gas exporter reported second-quarter earnings. Sunseeking Germans Face Swiss Backlash Over Alpine Holiday Congestion New York Warns of $34 Billion Budget Hole, Biggest Since 2009 Crisis To Head Off Severe Storm Surges, Nova Scotia Invests in 'Living Shorelines' Five Years After Black Lives Matter, Brussels' Colonial Statues Remain For Homeless Cyclists, Bikes Bring an Escape From the Streets Shares on Tuesday eked out a 0.9% gain after the company beat on revenue and said one of a set of arbitration cases would be decided 'imminently.' The rise barely offset the stock's recent losses, Venture Global still trades at less than half of its January initial public offering price of $25 a share. 'We saw the IPO price as priced for perfection in execution,' said Adam Baker, a Morningstar Investment Service analyst who rates the stock a hold. 'They have grand visions and some of those visions won't be realized into the 2030s.' The Arlington, Virginia-based company is being hit by a triple whammy of volatile LNG pricing, ongoing arbitration, and an enormous debt pile. That's helped cement this year's biggest US IPO as the worst-performing among those raising over $50 million, according to data compiled by Bloomberg. Venture Global reported $3.1 billion in revenue for the quarter, beating the average analyst estimate of $2.9 billion while net income of $368 million missed by 39%. Lower liquefied natural gas prices at the Louisiana Calcasieu Project offset higher sales volumes at other projects. 'They're a company in heavy growth mode and they're building very expensive facilities and they're pursuing a minimum amount of those volumes being contracted,' Baker said. 'So their stock share price is going to be volatile and track movements in Dutch LNG indexes.' This marked the firm's second earnings print since it went public, in a $1.75 billion IPO. Venture Global shares fell 4% in its first day of trading, even after the company had already scaled back its price range by more than 40%, having sought as much as $46 a share. Even expedited project approvals under the Trump administration have failed to reignite shares and the biggest bulls have price targets below the IPO price. Hedgeye Risk Management analyst Fernando Valle rates the stock a buy and sees $18 to $20 as a fair price for the shares. He expects the company to benefit over the next five to 15 years from the US cost advantage in natural gas. Meanwhile, Dutch TTF Natural Gas Futures are down over 30% this year as higher inventories in Europe and the US weigh on prices and the stock. Another focus for investors has been the company's arbitration. Venture Global faces nearly $6 billion in pending arbitration claims stemming from its Calcasieu LNG plant which began producing in 2022, but didn't deliver gas to its customers until 2025. Hedgeye's Valle says a negative impact from arbitration has already been priced in, but a positive result from the first decision could set the tone for future cases and change the outlook. Valle says investors are split on Venture Global, with some concerned about a lack of clarity around pricing structures. Wall Street is also split on the company; among the 16 tracked by Bloomberg, one half gives it a buy-equivalent rating and the rest assigns it a hold-equivalent grade. 'There are people who love it and people who certainly don't,' Valle said in an interview. 'The don'ts are really more concerned about management and the communication, and the ones that love it just see the value of the assets and the long-term contract and also the speed of execution.' --With assistance from Jaren Kerr. (Updates with closing share move.) Bessent on Tariffs, Deficits and Embracing Trump's Economic Plan Why It's Actually a Good Time to Buy a House, According to a Zillow Economist The Social Media Trend Machine Is Spitting Out Weirder and Weirder Results Dubai's Housing Boom Is Stoking Fears of Another Crash A $340 Million New York Office Makeover Is Converting Boardrooms to Bedrooms ©2025 Bloomberg L.P.

AI can make us UK's biggest firm, Rolls-Royce says
AI can make us UK's biggest firm, Rolls-Royce says

Yahoo

time35 minutes ago

  • Yahoo

AI can make us UK's biggest firm, Rolls-Royce says

Rolls-Royce's plan to power artificial intelligence (AI) with its nuclear reactors could make it the UK's most valuable company, its boss has said. The engineering firm has signed deals to provide small modular reactors (SMRs) to the UK and Czech governments to power AI-driven data centres. AI has boomed in popularity since 2022, but the technology use lots of energy, something which has raised practical and environmental concerns. Rolls-Royce chief executive Tufan Erginbilgic told the BBC it has the "potential" to become the UK's highest-valued company by overtaking the largest firms on the London Stock Exchange thanks to its SMR deals. "There is no private company in the world with the nuclear capability we have. If we are not market leader globally, we did something wrong," he said. Tufan Erginbilgic has overseen a ten-fold increase in Rolls-Royce's share price since taking over in January 2023. However, he has ruled out the idea of Rolls-Royce seeking to list its shares in New York as British chip designer Arm has done and the likes of Shell and AstraZeneca have considered in the search for higher valuations. This is despite the fact that 50% of its shareholders and customers are US-based. "It's not in our plan," said Mr Erginbilgic, a Turkish energy industry veteran. "I don't agree with the idea you can only perform in the US. That's not true and hopefully we have demonstrated that." AI investment Rolls-Royce already supplies the reactors that power dozens of nuclear submarines. Mr Erginbilgic said the company has a massive advantage in the future market of bringing that technology on land in the form of SMRs. SMRs are not only smaller but quicker to build than traditional nuclear plants, with costs likely to come down as units are rolled out. He estimates that the world will need 400 SMRs by 2050. At a cost of up to $3bn (£2.2bn) each, that's another trillion dollar-plus market he wants and expects Rolls-Royce to dominate. The company has signed a deal to develop six SMRs for the Czech Republic and is developing three for the UK. But it remains an unproven technology. Mr Erginbilgic conceded he could not currently point to a working SMR example but said he was confident in its future potential. There are also concerns about the demands on water supplies from the data centre and SMR cooling systems. In response, companies including Google, Microsoft and Meta have signed deals to take energy from SMRs in the US when they are available. Next generation aircraft Rolls-Royce sees SMRs as key to its future, but its biggest business is aircraft engines. Already dominant in supplying engines to wide-bodied aircraft like Boeing 787 and Airbus A350, it plans to break into the next generation of narrow-bodied aircraft like the Boeing 737 and Airbus A320. This market is worth $1.6tn - nine times that of the wide-bodied . Rolls-Royce is a bit player in a market that has powerful and successful leaders, and that rival Pratt and Witney lost $8bn trying and failing to break into. The market is dominated by CFM International – a joint venture between US-based GE Aerospace and French company Safran Aerospace Engines. Industry veterans told the BBC that market leaders can and will drop prices to airline customers long enough to see off a new assault on their market dominance. But Mr Erginbilgic said this is not just the biggest business opportunity for Rolls-Royce. Rather, it is "for industrial strategy... the single biggest opportunity for the UK for economic growth". "No other UK opportunity, I challenge, will match that," he said. Share price up ten-fold Although Rolls-Royce sold its car making business to BMW nearly 30 years ago, the name of the company is still synonymous with British engineering excellence. But in the early part of this decade that shine had worn off. The company was heavily indebted, its profit margins were non-existent, and thousands of staff were being laid off. When Mr Erginbilgic took over in January 2023, he likened the company to "a burning platform". "Our cost of capital was 12%, our return was 4% so every time we invested we destroyed value," he said. Two and a half years later, the company expects to make a profit of over £3bn, its debt levels have fallen and shares have risen over 1,000% - a ten-fold rise. So how did that happen? And is Mr Erginbilgic right to think that Rolls-Royce's roll is only just starting? 'Grudging respect' The timing of his appointment was fortunate according to some industry veterans. Rolls-Royce's biggest business – supplying engines to commercial airlines – has rebounded strongly from the Covid pandemic. The company's most successful product – the Trent series of aircraft engines – are at the sweet spot of profitability as the returns on investment in their development over a decade ago begin to pour into company coffers. Russia's full-scale invasion of Ukraine in 2022 arguably made it almost inevitable that its defence business would see higher spending from European governments – which has been confirmed by recent announcements. Unions have not always been fans of Mr Erginbilgic's hard-charging approach. In October 2023, one of his first major move was cutting jobs, which drew criticism from Sharon Graham, the boss of the Unite union. "This announcement appears to be about appeasing the markets and its shareholders while ignoring its workers," she said at the time. However, overall global headcount has grown from 43,000 to 45,000 since 2023 and union sources say there is "grudging respect" for Mr Erginbilgic. Those sources give him one third of the credit for the turnaround around in the company's fortunes, with a third credited to market conditions and a third to his predecessor Warren East for "steadying the ship". So does Mr Erginbilgic really believe that Rolls-Royce can be the UK's most valuable company – overtaking the likes of AstraZeneca, HSBC, and Shell? "We are now number five in the FTSE. I believe the growth potential we created in the company right now, in our existing business and our new businesses, actually yes – we have that potential." Rolls-Royce is undoubtedly a company with the wind at its back – and Tufan Ergenbilgic certainly believes he has set the sails just right. What is AI, how does it work and why are some people concerned about it? Warning AI could use as much energy as Netherlands

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store